REICIN ALISE (PRES., GLOBAL CLINICAL DEV.) received a stock award from CELGENE CORP /DE/
Compensation award — not an open‑market transaction. Less informative as a directional signal.
Common Stock
Shares
+4.30K
Price / share
—
Trade value
—
% of position
Common Stock
Shares
+8.93K
Price / share
—
Trade value
—
% of position
Common Stock
Shares
+24.21K
Price / share
—
Trade value
—
% of position
Common Stock
Shares
−44.62K
Price / share
—
Trade value
—
% of position
Net shares
−7.18K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/20/2019 | A · Award | +4.30K | — | — | 59.9% | 7.18K | 11.48K |
| Common Stock Direct | 11/20/2019 | A · Award | +8.93K | — | — | 77.8% | 11.48K | 20.41K |
| Common Stock Direct | 11/20/2019 | A · Award | +24.21K | — | — | 118.6% | 20.41K | 44.62K |
| Common Stock Direct | 11/20/2019 | D · Disposition | −44.62K | — | — | New position | 44.62K | 0.00 |
| Total | −7.18K | $0.00 | ||||||
Stock Option (right to buy)
Common Stock
42.50K shares
Shares
−42.50K
Strike price
75.61
Held after
0.00
Exercisable
—
Restricted Stock Unit
Common Stock
23.81K shares
Shares
−23.81K
Strike price
Held after
0.00
Exercisable
—
Restricted Stock Unit
Common Stock
37.66K shares
Shares
−37.66K
Strike price
Held after
0.00
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock42.50K shares | 11/20/2019 | D · Disposition | −42.50K | 75.61 | — | 0.00 |
| Restricted Stock Unit Direct | Common Stock23.81K shares | 11/20/2019 | D · Disposition | −23.81K | — | 0.00 | |
| Restricted Stock Unit Direct | Common Stock37.66K shares | 11/20/2019 | D · Disposition | −37.66K | — | 0.00 |